Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Summary

The objectives of this first-in-human is to evaluate the safety and the immunogenicity of three administrations of a bivalent vaccine candidate against human cytomegalovirus, at three different dose levels.

Timeline

Start

2016-06

Primary completion

2017-05

Completion

2018-03

Drugs

Indications